Total Payments
$1,523
2024 Payments
$125.00
Companies
10
Transactions
24
Medicare Patients
611
Medicare Billing
$74,300
Payment Breakdown by Category
Food & Beverage$1,424 (93.5%)
Education$99.00 (6.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,424 | 23 | 93.5% |
| Education | $99.00 | 1 | 6.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $255.08 | 4 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $236.08 | 3 | $0 (2019) |
| GlaxoSmithKline, LLC. | $230.45 | 2 | $0 (2021) |
| ABBVIE INC. | $220.43 | 2 | $0 (2024) |
| Foundation Medicine, Inc. | $209.38 | 6 | $0 (2018) |
| Clovis Oncology, Inc. | $127.51 | 3 | $0 (2019) |
| Novo Nordisk Inc | $76.05 | 1 | $0 (2017) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $75.23 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $74.24 | 1 | $0 (2019) |
| BAXTER HEALTHCARE | $18.92 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.00 | 1 | ABBVIE INC. ($125.00) |
| 2021 | $125.00 | 1 | GlaxoSmithKline, LLC. ($125.00) |
| 2020 | $105.45 | 1 | GlaxoSmithKline, LLC. ($105.45) |
| 2019 | $354.49 | 4 | TESARO, Inc. ($104.72) |
| 2018 | $77.83 | 2 | AstraZeneca Pharmaceuticals LP ($63.90) |
| 2017 | $735.60 | 15 | Foundation Medicine, Inc. ($195.45) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/07/2024 | ABBVIE INC. | ELAHERE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 07/15/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 08/12/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $105.45 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $99.00 | General |
| Category: Oncology | ||||||
| 08/13/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $104.72 | General |
| Category: ONCOLOGY | ||||||
| 05/21/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $74.24 | General |
| Category: Oncology | ||||||
| 02/18/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $76.53 | General |
| Category: Oncology | ||||||
| 07/20/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 05/14/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $63.90 | General |
| Category: Oncology | ||||||
| 12/15/2017 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Oncology | ||||||
| 11/02/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: ONCOLOGY | ||||||
| 10/12/2017 | BAXTER HEALTHCARE | FLOSEAL (Biological) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Surgical Care | ||||||
| 10/06/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2017 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Oncology | ||||||
| 08/31/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $119.62 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2017 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $95.65 | General |
| Category: Oncology | ||||||
| 08/18/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: ONCOLOGY | ||||||
| 06/30/2017 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: ONCOLOGY | ||||||
| 06/15/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $85.91 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2017 | TESARO, Inc. | VARUBI (Drug), ZEJULA | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: ONCOLOGY | ||||||
| 05/04/2017 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $45.56 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2017 | AbbVie, Inc. | Androgel (Drug) | Food and Beverage | In-kind items and services | $95.43 | General |
| Category: Endocrinology | ||||||
| 02/15/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $76.05 | General |
| Category: Obesity | ||||||
| 01/17/2017 | Otsuka Pharmaceutical Development & Commercialization, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $75.23 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 85 | 107 | $17,355 | $4,106 |
| 2021 | 7 | 230 | 464 | $95,202 | $33,074 |
| 2020 | 10 | 296 | 494 | $119,869 | $37,120 |
Total Patients
611
Total Services
1,065
Medicare Billing
$74,300
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 94 | $15,886 | $3,741 | 23.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 13 | $1,469 | $364.92 | 24.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 115 | 294 | $49,686 | $18,266 | 36.8% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 13 | 13 | $30,069 | $9,487 | 31.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 36 | 47 | $5,311 | $1,824 | 34.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $4,940 | $1,710 | 34.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 45 | $3,996 | $1,372 | 34.3% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 18 | 20 | $1,000 | $339.97 | 34.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 14 | 25 | $200.00 | $75.00 | 37.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 132 | 297 | $50,193 | $15,538 | 31.0% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2020 | 16 | 16 | $37,008 | $10,635 | 28.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 32 | $7,552 | $2,680 | 35.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $6,392 | $2,092 | 32.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $4,950 | $1,826 | 36.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 37 | 51 | $5,763 | $1,758 | 30.5% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 21 | 21 | $5,187 | $1,620 | 31.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 17 | $1,560 | $542.04 | 34.7% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 13 | 16 | $800.00 | $252.78 | 31.6% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 14 | 16 | $464.00 | $175.05 | 37.7% |
About Dr. Edward Podczaski, MD
Dr. Edward Podczaski, MD is a Gynecologic Oncology healthcare provider based in Hershey, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841254463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Podczaski, MD has received a total of $1,523 in payments from pharmaceutical and medical device companies, with $125.00 received in 2024. These payments were reported across 24 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($1,424).
As a Medicare-enrolled provider, Podczaski has provided services to 611 Medicare beneficiaries, totaling 1,065 services with total Medicare billing of $74,300. Data is available for 3 years (2020–2022), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Location Hershey, PA
- Active Since 04/12/2006
- Last Updated 12/11/2023
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1841254463
Products in Payments
- ZEJULA (Drug) $466.64
- LYNPARZA (Drug) $236.08
- FOUNDATIONONE (Device) $209.38
- Rubraca (Drug) $127.51
- ELAHERE (Drug) $125.00
- Androgel (Drug) $95.43
- Saxenda (Drug) $76.05
- SAMSCA (Drug) $75.23
- OPDIVO (Biological) $74.24
- FLOSEAL (Biological) $18.92
- VARUBI (Drug) $18.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.